Abstract
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States and a significant public health problem in most industrialized nations. Since 1900, it has been the leading cause of death in the United States every year except 1918 [1]. In 2005, CVD afflicted 80 million Americans and caused 864,500 deaths. Meanwhile, the number of people with CVD, and especially its advanced forms, has been increasing. There are two main reasons for this. First, although there is still no cure for CVD, palliative therapy has improved to the point that more people are surviving past their initial episodes of CVD to live on with some form of the disease. Second, the average age of the US population is rising as the “baby boom” generation ages.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Heart Association. Heart and stroke statistical update. 2002. Available at http://www.americanheart.org. Accessed Oct 2005.
Frazier OH, Myers TJ. Surgical therapy for severe heart failure [review]. Curr Probl Cardiol. 1998;23:721.
United Network for Organ Sharing. Critical data: U.S. Facts about transplantation. Available at http://www.unos.org. Accessed Apr 2002.
Kirklin JW, DuShane JW, Patrick RT, et al. Intracardiac surgery with the aid of a mechanical pump-oxygenator system (Gibbon type): report of eight cases. Staff Meet Mayo Clin. 1955;30:201.
Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122:1186.
Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435.
Mueller J, Weng Y, Dandel M. Long-term results of weaning from LVAD: it does work. ASAIO J. 1999;45:153.
Frazier OH, Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg. 1999;68(2 Suppl):734.
LeGallois CJJ. Experience on the Principle of Life. Philadelphia, Thomas, 1813. Translation of LeGallois CJJ: Experience sur la principe de la vie. Paris. 1812.
Miller GW. King of hearts: the true story of the maverick who pioneered open heart surgery. New York: Random House; 2000.
Dennis C. A heart-lung machine for open-heart operations: how it came about. Trans Am Soc Artif Intern Organs. 1989;35:767.
Gibbon JH. Application of a heart and lung apparatus to cardiac surgery. Minn Med. 1954;37:171.
Lillehei CW, Cohen M, Warden HE, Varco RL. The direct-vision intracardiac correction of congenital anomalies by controlled cross circulation. Surgery. 1955;38:11.
Lillehei CW, DeWall RA, Read R, et al. Direct-vision intracardiac surgery in man using a simple, disposable artificial oxygenator. Dis Chest. 1956;29:1.
Akutsu T, Kolff WJ. Permanent substitute for valves and hearts. Trans Am Soc Artif Intern Organs. 1958;4:230.
DeBakey ME. Left ventricular bypass for cardiac assistance: clinical experience. Am J Cardiol. 1971;27:3.
Cooley DA, Liotta D, Hallman GL, et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969;24:723.
DeVries WC. The permanent artificial heart: four case reports. JAMA. 1988;259:849.
DeVries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N Engl J Med. 1984;310:273.
Copeland CG, Smith RG, Icenogle TB, Ott RA. Early experience with the total artificial heart as a bridge to cardiac transplantation. Surg Clin North Am. 1988;68:621.
Johnson KE, Prieto M, Joyce LD, et al. Summary of the clinical use of the Symbion total artificial heart: a registry report. Ann Surg. 1995;222:327.
Copeland JG. Current status and future directions for a total artificial heart with a past. Artif Organs. 1998;22:998.
Copeland JG, Smith RG, Arabia FA, et al. and the CardioWest Total Artificial Heart Investigators: cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859.
SoRelle R. Cardiovascular news. Totally contained AbioCor artificial heart implanted July 3, 2001. Circulation. 2001;104:E9005.
Kung RTV, Yu LS, Ochs BD, et al. Progress in the development of the ABIOMED total artificial heart. ASAIO J. 1995;41:M245.
Parnis SM, Yu LS, Ochs BD, et al. Chronic in vivo evaluation of an electrohydraulic total artificial heart. ASAIO J. 1994;40:M489.
Kung RTV, Yu LS, Ochs BD, et al. An artificial hydraulic shunt in a total artificial heart: a balance mechanism for the bronchial shunt. ASAIO J. 1993;39:M213.
Yu LS, Finnegan M, Vaughan S, et al. A compact and noise-free electrohydraulic total artificial heart. ASAIO J. 1993;39:M386.
Quaini E, Pavie A, Chieco S, Mambrito B. The Concerted Action ‘Heart’ European registry on clinical application of mechanical circulatory support systems: bridge to transplant. The Registry Scientific Committee. Eur J Cardiothorac Surg. 1997;11:182.
Mehta SM, Aufiero TX, Pae WE Jr, et al. Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: sixth official report—1994. J Heart Lung Transplant. 1995;14:585.
Myers TJ, Khan T, Frazier OH. Infectious complications associated with ventricular assist systems. ASAIO J. 2000;46:S28.
Conger JL, Inman RW, Tamez D, et al. Infection and thrombosis in total artificial heart technology: past and future challenges—a historical review. ASAIO J. 2000;46:S22.
Arabia FA, Copeland JG, Smith RG, et al. International experience with the CardioWest total artificial heart as a bridge to heart transplantation. Eur J Cardiothorac Surg. 1997;11(Suppl):S5.
Gristina AG, Dobbins JJ, Giammara B, et al. Biomaterial-centered sepsis and the total artificial heart: microbial adhesion versus tissue integration. JAMA. 1988;259:870.
Joyce LD, DeVries WC, Hastings WL, et al. Response of the human body to the first permanent implant of the Jarvik-7 total artificial heart. Trans Am Soc Artif Intern Organs. 1983;29:81.
DeVries WC. Surgical technique for implantation of the Jarvik-7-100 total artificial heart. JAMA. 1988;259:875.
Copeland JG 3rd, Smith RG, Arabia FA, et al. Comparison of the CardioWest total artificial heart, the Novacor left ventricular assist system, and the Thoratec ventricular assist system in bridge to transplantation. Ann Thorac Surg. 2001;71(3 Suppl):S92.
Copeland JG, Smith RG, Arabia FA, et al. The CardioWest total artificial heart as a bridge to transplantation. Semin Thorac Cardiovasc Surg. 2000;12:238.
Copeland JG, Pavie A, Duveau D, et al. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993 to 1995. J Heart Lung Transplant. 1995;15(1 Pt1):94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Li, Y., Xu, Z. (2024). Total Artificial Heart. In: Tang, YD., Yang, J., Zheng, Y., Li, Y., Zeng, Y. (eds) Application of Biomaterials in the Treatment of Cardiovascular Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-19-7712-1_11
Download citation
DOI: https://doi.org/10.1007/978-981-19-7712-1_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-7711-4
Online ISBN: 978-981-19-7712-1
eBook Packages: MedicineMedicine (R0)